Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
Gastroenterology
    June 2024
  1. HSU BY, Driscoll J, Tateno C, Mattis AN, et al
    Human Hepatocytes Can Give Rise To Intrahepatic Cholangiocarcinomas.
    Gastroenterology. 2024 Jun 10:S0016-5085(24)05028.
    >> Share

  2. LEE BP, Louvet A
    Longitudinal Change of Alcohol Use is a Dynamic Contributor to Steatotic Liver Disease Progression.
    Gastroenterology. 2024;166:965-967.
    >> Share

  3. LO GH
    The Optimal Duration of Vasoconstrictors for Acute Variceal Hemorrhage: Longer Is Safer?
    Gastroenterology. 2024;166:1197-1198.
    >> Share

  4. WANG H, Yuan S, Zheng Q, Zhang S, et al
    Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs.
    Gastroenterology. 2024;166:1130-1144.
    >> Share

    May 2024
  5. HANSCOM M
    Magnetically guided capsule endoscopy comparable to EGD for detecting esophagogastric varices in patients with cirrhosis.
    Gastroenterology. 2024 May 28:S0016-5085(24)05001.
    >> Share

  6. HILSCHER MB, Wysokinski WE, Andrews JC, Simonetto DA, et al
    Portal Vein Thrombosis in the Setting of Cirrhosis: Evaluation and Management Strategies.
    Gastroenterology. 2024 May 25:S0016-5085(24)04951.
    >> Share

  7. CHANG M, Hammami MB, Sakiani S
    A Case of Hepatobiliary Challenges: Unraveling the Mystery of Bile Duct Disappearance.
    Gastroenterology. 2024 May 14:S0016-5085(24)04914.
    >> Share

  8. NIEMI NM, Debosch BJ
    Survival of the Fittest: Clonal Selection of Somatic Mutations Reveals Targets to Abate Chronic Liver Injury.
    Gastroenterology. 2024;166:936-937.
    >> Share

  9. GEORGE B, Kudryashova O, Kravets A, Thalji S, et al
    Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
    Gastroenterology. 2024;166:859-871.
    >> Share

  10. SCHONAUER R, Sierks D, Boerrigter M, Jawaid T, et al
    Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease.
    Gastroenterology. 2024;166:902-914.
    >> Share

    April 2024
  11. WANG L, Berger NA, Kaelber DC, Xu R, et al
    Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes.
    Gastroenterology. 2024 Apr 29:S0016-5085(24)00494.
    >> Share

  12. JIANG C, Lian M, Ma X
    A Rare Case Mimicking Congenital Hepatic Fibrosis.
    Gastroenterology. 2024 Apr 23:S0016-5085(24)00483.
    >> Share

    March 2024
  13. CAMPANI C, Guido M, Marra F
    Elusive hepatic nodules.
    Gastroenterology. 2024 Mar 23:S0016-5085(24)00355.
    >> Share

  14. HOLTZ LR, DeBosch BJ
    Deploying Lactulose as a Prebiotic to Reduce Complications of Chronic Liver Disease.
    Gastroenterology. 2024;166:534-535.
    >> Share

  15. URIAS E, Tedesco NR, Oliveri A, Raut C, et al
    PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment.
    Gastroenterology. 2024;166:515-517.
    >> Share

  16. GAO F, Seto WK, Zheng MH
    Preventing Overdiagnosis of Nonalcoholic Fatty Liver Disease: Established Cutoff Values for Transient Elastography Are Needed.
    Gastroenterology. 2024;166:541-542.
    >> Share

  17. AN T, Liu L, Li X
    Factors Associated With the Influence of Liver Fibrosis Should Be Fully Considered.
    Gastroenterology. 2024;166:540-541.
    >> Share

    February 2024
  18. WONG RJ, Yang Z, Cheung R, Singal AK, et al
    Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among U.S. Veterans with Steatotic Liver Disease.
    Gastroenterology. 2024 Feb 28:S0016-5085(24)00238.
    >> Share

  19. CHEN J, Feng W, Sun M, Huang W, et al
    TGF-beta1 Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis through Transcriptionally Upregulating PD-L1 and CXCL12.
    Gastroenterology. 2024 Feb 26:S0016-5085(24)00187.
    >> Share

  20. ALLEN AM, Pose E, Reddy KR, Russo MW, et al
    Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress But With Challenges.
    Gastroenterology. 2024;166:229-234.
    >> Share

  21. WALAYAT S, Pfau P
    2 AM in the Intensive Care Unit: What Could Go Wrong?
    Gastroenterology. 2024;166:e13-e15.
    >> Share

  22. BILAL M, Steinberg J, Louissaint J, Phan J, et al
    First Year on the Job as a Gastroenterologist and Hepatologist: Lessons Learned.
    Gastroenterology. 2024 Feb 1:S0016-5085(24)00125.
    >> Share

    January 2024
  23. POSE E, Piano S, Juanola A, Gines P, et al
    HEPATORENAL SYNDROME IN CIRRHOSIS.
    Gastroenterology. 2024 Jan 19:S0016-5085(24)00054.
    >> Share

  24. LAURIDSEN MM, Gronkjaer LL, Khraibut S, Patel N, et al
    The multi-dimensional challenge of poor oral health in cirrhosis - disparities and solutions.
    Gastroenterology. 2024 Jan 13:S0016-5085(24)00043.
    >> Share

  25. MULLISH BH
    Risk Factors for Liver Cancer and Chronic Liver Disease-related Death: Are Sugar Substitutes Better Than the Real Thing?
    Gastroenterology. 2024;166:213-214.
    >> Share

  26. ZENG Q, Wu D, Tang H
    A Mysterious Abdominal Pain.
    Gastroenterology. 2024;166:27-30.
    >> Share

    December 2023
  27. MEZZACAPPA C, Bhat M
    Proteomic Panels for Alcohol-Associated Liver Disease: Accurate, but Different Enough From Existing Clinical Tests?
    Gastroenterology. 2023;165:1576.
    >> Share

    November 2023
  28. GARCIA-TSAO G, Abraldes JG, Rich NE, Wong VW, et al
    AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.
    Gastroenterology. 2023 Nov 17:S0016-5085(23)05143.
    >> Share

  29. KOJIMA H, Kadono K, Hirao H, Dery KJ, et al
    T Cell CEACAM1-TIM-3 Crosstalk Alleviates Liver Transplant Injury in Mice and Humans.
    Gastroenterology. 2023;165:1233-1248.
    >> Share

  30. PENA-SANCHEZ JN, Osei JA, Teucher U, Tremblay M, et al
    Working With Indigenous Community and Patient Partners Is Essential to Advance Gastroenterology and Hepatology Research: Perspectives From Canada.
    Gastroenterology. 2023;165:1097-1101.
    >> Share

  31. LLOVET JM, Heikenwalder M
    Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology.
    Gastroenterology. 2023;165:1308-1310.
    >> Share

    October 2023
  32. AMPUERO J, Berzigotti A
    Prognostication in Advanced Chronic Liver Disease Using Liver Stiffness Measurement: Repetita Iuvant.
    Gastroenterology. 2023;165:829-831.
    >> Share

  33. SEMMLER G, Yang Z, Fritz L, Kock F, et al
    Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
    Gastroenterology. 2023;165:1041-1052.
    >> Share

  34. MAN S, Deng Y, Ma Y, Fu J, et al
    Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China.
    Gastroenterology. 2023;165:1025-1040.
    >> Share

  35. YIP TC, Fan JG, Wong VW
    China's Fatty Liver Crisis: A Looming Public Health Emergency.
    Gastroenterology. 2023;165:825-827.
    >> Share

  36. TICA S, Debosch BJ
    Bariatric Surgery for the Treatment of NASH-An Old Solution to a Newer Problem?
    Gastroenterology. 2023;165:1091.
    >> Share

  37. WATTACHERIL JJ, Abdelmalek MF, Lim JK, Sanyal AJ, et al
    AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2023;165:1080-1088.
    >> Share

    September 2023
  38. CHEN J, Yang Q, Wang C
    Multiple Hepatic Masses in a Patient with Crohn's disease.
    Gastroenterology. 2023 Sep 20:S0016-5085(23)05014.
    >> Share

  39. XIE L, Guo H
    Question on the use of BMI >/= 25 kg/m(2) to define obesity to analyze the incidence and risk factors of hepatic steatosis and hepatic fibrosis in the Chinese population.
    Gastroenterology. 2023 Sep 8:S0016-5085(23)04983.
    >> Share

  40. MEZZACAPPA C
    Survival in unresectable hepatocellular carcinoma treated with a new immune checkpoint and anti-angiogenic drug combination.
    Gastroenterology. 2023 Sep 6:S0016-5085(23)04976.
    >> Share

  41. NEWMAN KL, Velez C, Paul S, Radix AE, et al
    Research Considerations in Digestive and Liver Disease in Transgender and Gender-Diverse Populations.
    Gastroenterology. 2023;165:523-528.
    >> Share

  42. WANG Y, Huang Y, Chase RC, Li T, et al
    Global Burden of Digestive Diseases: A Systematic Analysis of the Global Burden of Diseases Study, 1990 to 2019.
    Gastroenterology. 2023;165:773-783.
    >> Share

  43. INTAGLIATA NM, Rahimi RS, Higuera-de-la-Tijera F, Simonetto DA, et al
    Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): An International, Prospective, Multicenter Observational Study.
    Gastroenterology. 2023;165:717-732.
    >> Share

  44. ZUO T, Xie Q, Liu J, Yang J, et al
    Macrophage-Derived Cathepsin S Remodels the Extracellular Matrix to Promote Liver Fibrogenesis.
    Gastroenterology. 2023;165:746-761.
    >> Share

  45. FLIGOR SC, Tsikis ST, Hirsch TI, Pan A, et al
    A Medium-Chain Fatty Acid Analogue Prevents Intestinal Failure-Associated Liver Disease in Preterm Yorkshire Piglets.
    Gastroenterology. 2023;165:733-745.
    >> Share

  46. WASSERMAN R, Reddy S, Grider D
    An Unusual Manifestation of Elevated Liver Enzymes and Architecture.
    Gastroenterology. 2023;165:e4-e6.
    >> Share

    August 2023
  47. HUANG DQ, Wilson LA, Behling C, Kleiner DE, et al
    Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.
    Gastroenterology. 2023;165:463-472.
    >> Share

  48. NAIMIMOHASSES S, Bhat M
    Genomic Analysis of Hair From Celebrated Composer Provides Insight Into Liver Disease Susceptibility.
    Gastroenterology. 2023;165:514.
    >> Share

  49. DEBOSCH BJ
    Next-Generation Farnesoid X Receptor Agonists in NASH Treatment: Are We There Yet?
    Gastroenterology. 2023;165:513-514.
    >> Share

  50. PENG Z, Li S, Pi R
    A Giant Cystic Liver Mass in an Elderly Man.
    Gastroenterology. 2023;165:e5-e7.
    >> Share

  51. ZHANG XF, Yin ZK, Zhang JY
    An Unusual Case of Intermittent Fever With Multiple Liver Lesions.
    Gastroenterology. 2023;165:e11-e14.
    >> Share

  52. KHAN AA, Turki M, Frandah W
    An Unusual Case of Hematemesis.
    Gastroenterology. 2023;165:e8-e10.
    >> Share

  53. SHEN C, Zhang J, Xia Q
    Unexpected Abdominal Wall Varices After Split-Liver Transplantation.
    Gastroenterology. 2023;165:354-356.
    >> Share

    July 2023
  54. REDDY KR, McLerran D, Marsh T, Parikh N, et al
    Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: the Multi-center Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.
    Gastroenterology. 2023 Jul 8:S0016-5085(23)04765.
    >> Share

  55. LO YN, Wu JS, Chiang HC
    A Pseudo-Gastric Bubble.
    Gastroenterology. 2023;165:e16-e18.
    >> Share

  56. LI GF, Yu G
    Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System.
    Gastroenterology. 2023;165:305-306.
    >> Share

  57. DEBOSCH B
    Obeying the Law: Energy Balance in Alternate-Day Fasting, Exercise, or Both Together in Patients With Obesity and NAFLD.
    Gastroenterology. 2023;165:301.
    >> Share

  58. RATZIU V, Friedman SL
    Why Do So Many Nonalcoholic Steatohepatitis Trials Fail?
    Gastroenterology. 2023;165:5-10.
    >> Share

    June 2023
  59. NISHIWAKI T, Tsutsumi Y, Nakaji S
    A mysterious hepatic mass.
    Gastroenterology. 2023 Jun 15:S0016-5085(23)00879.
    >> Share

  60. CHINNASAMY V, Sakulsaengprapha V, Mathews SC
    The Benefit of Artificial Intelligence-Based Diagnosis in Gastroenterology and Hepatology is Highly Variable: A Diagnostic Need and Burden Analysis.
    Gastroenterology. 2023 Jun 2:S0016-5085(23)00818.
    >> Share

  61. THIELE M, Suvitaival T, Trost K, Kim M, et al
    Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis.
    Gastroenterology. 2023;164:1248-1260.
    >> Share

  62. SCHEINER B, Pinato DJ
    Tumor-infiltrating Neutrophils: Gatekeepers in Liver Cancer Immune Control.
    Gastroenterology. 2023;164:1338-1339.
    >> Share

  63. MULLISH BH
    The Impact of Proportional Dietary Carbohydrate and Fat Content on Type 2 Diabetes and NAFLD.
    Gastroenterology. 2023;164:1338.
    >> Share

  64. LIU W, Wei DH, Tong QY
    The Bull's-Eye Sign in Liver: Are They Liver Metastases?
    Gastroenterology. 2023;164:1056-1058.
    >> Share

    May 2023
  65. FARIAS AQ, Vilalta AC, Zitelli PM, Pereira G, et al
    Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America.
    Gastroenterology. 2023 May 30:S0016-5085(23)00806.
    >> Share

  66. YANG XM, Wang XQ, Hu LP, Feng MX, et al
    Nucleolar HEATR1 upregulated by mTORC1 signaling promotes hepatocellular carcinoma growth by dominating ribosome biogenesis and proteome homeostasis.
    Gastroenterology. 2023 May 27:S0016-5085(23)00802.
    >> Share

  67. WANG J, Yu H, Dong W, Zhang C, et al
    N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/beta-Catenin and Hippo Signaling Pathways.
    Gastroenterology. 2023;164:990-1005.
    >> Share

    April 2023
  68. CHO MY, Sung PS, Lee SH
    Multiple Hepatic Artery Pseudoaneurysms with Eosinophilia.
    Gastroenterology. 2023 Apr 26:S0016-5085(23)00629.
    >> Share

  69. HAN H, Ge X, Babu Komakula SS, Desert R, et al
    MACROPHAGE-DERIVED OSTEOPONTIN (SPP1) PROTECTS FROM NON-ALCOHOLIC STEATOHEPATITIS.
    Gastroenterology. 2023 Apr 5:S0016-5085(23)00581.
    >> Share

  70. GOLDOWSKY A, Ding J, Velez C, Paul S, et al
    Improving the Experiences of Sexual and Gender Minority-Identifying Trainees in Gastroenterology and Hepatology.
    Gastroenterology. 2023;164:510-514.
    >> Share

  71. XU X, Alanaeme J, Wen Y, Colantonio LD, et al
    Real-World Implications of the American Gastroenterology Association Nonalcoholic Fatty Liver Disease Clinical Care Pathway in the US Adult Population.
    Gastroenterology. 2023;164:688-689.
    >> Share

  72. GADIYARAM S, Nachiappan M
    An Unusual Cause of Lower Gastrointestinal Bleeding.
    Gastroenterology. 2023;164:e4-e7.
    >> Share

    March 2023
  73. EINER C, Munk DE, Park E, Akdogan B, et al
    ARBM101 (Methanobactin SB2) drains excess liver copper via biliary excretion in Wilson Disease rats.
    Gastroenterology. 2023 Mar 24:S0016-5085(23)00529.
    >> Share

  74. GADIYARAM S, Nachiappan M, Kini D
    Liver SOL in a case of colon cancer, a red herring.
    Gastroenterology. 2023 Mar 24:S0016-5085(23)00534.
    >> Share

  75. KO PH, Tseng CW
    An Unusual Cause of Acute Cholecystitis.
    Gastroenterology. 2023 Mar 23:S0016-5085(23)00531.
    >> Share

  76. KUCUKKOSE E, Laoukili J, Gorelick AN, Degner S, et al
    Lymphatic invasion of plakoglobin-dependent tumor cell clusters drives formation of polyclonal lung metastases in colon cancer.
    Gastroenterology. 2023 Mar 9:S0016-5085(23)00256.
    >> Share

  77. SAITO Y, Yin D, Kubota N, Wang X, et al
    A therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23.
    Gastroenterology. 2023 Mar 7:S0016-5085(23)00235.
    >> Share

  78. ESPINOZA M, Muiquith M, Lim M, Zhu H, et al
    Disease etiology and outcomes after atezolizumab plus bevacizumab in hepatocellular carcinoma: Post-hoc analysis of IMbrave150.
    Gastroenterology. 2023 Mar 7:S0016-5085(23)00234.
    >> Share

  79. YANG S, Qian L, Li Z, Li Y, et al
    Integrated Multi-Omics Landscape of Liver Metastases.
    Gastroenterology. 2023;164:407-423.
    >> Share

  80. NICOLETTI P, Dellinger A, Li YJ, Barnhart HX, et al
    Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
    Gastroenterology. 2023;164:454-466.
    >> Share

  81. SUN J, Debosch B
    Guardian, Intermediary, or Perpetrator? New Insights Into Environmental Exposure, the Gut Microbiome, and Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2023;164:492.
    >> Share

  82. SHA M, Tong Y, Cao J
    "Malignant" Liver Lesions in an Incidental But High-Risk Patient.
    Gastroenterology. 2023;164:e17-e19.
    >> Share

  83. LIU R, Dai Z, Zhu C
    A Rare Cause of Liver Fibrosis in an Adolescent Woman.
    Gastroenterology. 2023;164:340-343.
    >> Share

  84. NADOLSKY KZ
    Use of the Term "Lean" for Nonalcoholic Fatty Liver Disease in Individuals With Low Body Mass Index.
    Gastroenterology. 2023;164:502-503.
    >> Share

  85. TAMBAKIS G, Florescu C, Tsoi E
    Three Lumens Full of Blood-An Unusual Case of Gastrointestinal Bleeding.
    Gastroenterology. 2023;164:334-335.
    >> Share

    February 2023
  86. L'HERMITE S, Bordet M, Rayer C
    A Woman With Recurrent Upper Gastrointestinal Bleeding.
    Gastroenterology. 2023 Feb 18:S0016-5085(23)00152.
    >> Share

  87. ZHOU C, Weng J, Liu C, Liu S, et al
    Disruption of SLFN11 deficiency-induced CCL2 signaling and macrophage M2 polarization potentiates anti-PD-1 therapy efficacy in hepatocellular carcinoma.
    Gastroenterology. 2023 Feb 14:S0016-5085(23)00137.
    >> Share

  88. CHEN VL, Oliveri A, Miller MJ, Wijarnpreecha K, et al
    PNPLA3 genotype and diabetes identify patients with non-alcoholic fatty liver disease at high risk of incident cirrhosis.
    Gastroenterology. 2023 Feb 7:S0016-5085(23)00113.
    >> Share

  89. TOH MR, Wong Yi Ting E, Wong Hei S, Ng Wei Tian A, et al
    Global epidemiology and genetics of hepatocellular carcinoma.
    Gastroenterology. 2023 Feb 2:S0016-5085(23)00105.
    >> Share

  90. UFERE NN, El-Jawahri A, Ritchie C, Lai JC, et al
    Promoting Prognostic Understanding and Health Equity for Patients With Advanced Liver Disease: Using "Best Case/Worst Case".
    Gastroenterology. 2023;164:171-176.
    >> Share

  91. PATEL AA, Arnold RM, Taddei TH, Woodrell CD, et al
    "Am I Going to Die?": Delivering Serious News to Patients With Liver Disease.
    Gastroenterology. 2023;164:177-181.
    >> Share

  92. DEBOSCH BJ
    A deCIDEdly New Germline Mutation That Protects Against Liver Disease.
    Gastroenterology. 2023;164:304-305.
    >> Share

  93. ZHU Y, Li X, He S
    Identification and Treatment of an Unusual Cause of Gastrointestinal Bleeding.
    Gastroenterology. 2023;164:e17-e20.
    >> Share

    January 2023
  94. XIAO X, Yao D, Yang J
    An uncommon upper gastrointestinal bleeding.
    Gastroenterology. 2023 Jan 27:S0016-5085(23)00052.
    >> Share

  95. LIM M, Franses JW, Imperial R, Majeed U, et al
    EGFR/ERBB2 amplifications and alterations associated with resistance to lenvatinib in hepatocellular carcinoma.
    Gastroenterology. 2023 Jan 25:S0016-5085(23)00056.
    >> Share

  96. WANG B, Bonkovsky HL, Lim JK, Balwani M, et al
    AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
    Gastroenterology. 2023 Jan 13:S0016-5085(22)01356.
    >> Share

  97. WONG GL, Hui VW, Yip TC, Lui GC, et al
    Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir.
    Gastroenterology. 2023;164:151-153.
    >> Share

  98. MITZLAFF K, Sayk F, Solbach P
    Jaundice and Weight Gain After Autologous Stem Cell Transplantation in a 28-Year-Old Patient With Diffuse Large B-Cell Lymphoma.
    Gastroenterology. 2023;164:32-33.
    >> Share

  99. SALIM Z, Laycock A, Hewavitharana C
    Abdominal Pain After Transarterial Chemoembolization.
    Gastroenterology. 2023;164:27-29.
    >> Share

    December 2022
  100. MO TT, Li M, Wang XY
    An Unusual Cause of Portal Hypertension.
    Gastroenterology. 2022 Dec 30:S0016-5085(22)01453.
    >> Share

  101. BLOCK PD, Farrell JJ, Li DK
    A Rare Cause of Gastrointestinal Bleeding after Pancreaticoduodenectomy.
    Gastroenterology. 2022 Dec 30:S0016-5085(22)01449.
    >> Share

  102. YEOH BS, Saha P, Golonka RM, Zou J, et al
    Enterohepatic Shunt-Driven Cholemia Predisposes to Liver Cancer.
    Gastroenterology. 2022;163:1658-1671.
    >> Share

  103. ZHU Y, Shi H, He S
    An Unusual Cause of Gastric Variceal Bleeding.
    Gastroenterology. 2022;163:1502-1504.
    >> Share

  104. ROBBINS J, El Hassan I, Siebenburgen C
    Evaluation and Treatment of GI Bleeding in a 51-Year-Old Man.
    Gastroenterology. 2022;163:1498-1501.
    >> Share

    November 2022
  105. OH AR, Jeong Y, Yu J, Minh Tam DT, et al
    Hepatocyte Kctd17 inhibition ameliorates glucose intolerance and hepatic steatosis caused by obesity-induced Chrebp stabilization.
    Gastroenterology. 2022 Nov 16:S0016-5085(22)01295.
    >> Share

  106. ZHANG H, Peng Y, Tang X
    Comments on "Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand".
    Gastroenterology. 2022 Nov 14. pii: S0016-5085(22)01271.
    >> Share

  107. WANG Z, Tai Y, Wu H
    A rare cause of abdominal pain after transjugular intrahepatic portosystemic shunt.
    Gastroenterology. 2022 Nov 10. pii: S0016-5085(22)01258.
    >> Share

  108. BRANDI G, Tovoli F, Tavolari S
    Have We Found the "Holy Grail" That May Predict Response to Immunotherapy in Hepatocellular Carcinoma?
    Gastroenterology. 2022 Nov 4. pii: S0016-5085(22)01252.
    >> Share

  109. PRASOPPOKAKORN T, Rerknimitr R
    An Unusual Complication of Endoscopic Cyanoacrylate Injection for Gastric Varix.
    Gastroenterology. 2022;163:1186-1187.
    >> Share

  110. MAGAHIS P, Rosenblatt R, Mahadev S
    An Unusual Cause of Right Upper Quadrant Pain With Abnormal Liver Enzymes.
    Gastroenterology. 2022;163:e3-e5.
    >> Share

    October 2022
  111. RAHAL HK, Tabibian JH, Issaka RB, Quezada S, et al
    Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand.
    Gastroenterology. 2022 Oct 7. pii: S0016-5085(22)00721.
    >> Share

  112. BEHARI J
    Needle-free Nonalcoholic Fatty Liver Disease Prognostication: Moving One Step Closer.
    Gastroenterology. 2022;163:819-822.
    >> Share

  113. AJMERA V, Kim BK, Yang K, Majzoub AM, et al
    Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
    Gastroenterology. 2022;163:1079-1089.
    >> Share

  114. SHINGINA A, Sarkar M, Feld L
    On the Importance of Safe Access to Reproductive Options for Adolescents and Women With Liver Disease.
    Gastroenterology. 2022;163:792-794.
    >> Share

  115. BAJAJ JS, Nagy LE
    Natural History of Alcohol-Associated Liver Disease: Understanding the Changing Landscape of Pathophysiology and Patient Care.
    Gastroenterology. 2022;163:840-851.
    >> Share

    September 2022
  116. LI H, Zheng J, Xu Q, Yang Y, et al
    Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation.
    Gastroenterology. 2022 Sep 28. pii: S0016-5085(22)01085.
    >> Share

  117. DARA L
    No Necroptosis in Hepatocytes: The Final Nail in the Coffin?
    Gastroenterology. 2022 Sep 22. pii: S0016-5085(22)01083.
    >> Share

  118. MURILLO PEREZ CF, Fisher H, Hiu S, Kareithi D, et al
    Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
    Gastroenterology. 2022 Sep 13. pii: S0016-5085(22)01060.
    >> Share

  119. HABER PK, Castet F, Torres-Martin M, Andreu-Oller C, et al
    Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.
    Gastroenterology. 2022 Sep 12. pii: S0016-5085(22)01039.
    >> Share

  120. LONG MT, Noureddin M, Lim JK
    AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
    Gastroenterology. 2022;163:764-774.
    >> Share

  121. LEE BP, Terrault NA
    Advocacy for Equity in Transplantation Access for Alcohol-Associated Liver Disease: How Research Changed Medi-Cal Policy.
    Gastroenterology. 2022;163:539-542.
    >> Share

    August 2022
  122. PRESTON SP, Stutz MD, Allison CC, Nachbur U, et al
    Epigenetic silencing of RIPK3 in hepatocytes prevents MLKL-mediated necroptosis from contributing to liver pathologies.
    Gastroenterology. 2022 Aug 26. pii: S0016-5085(22)01021.
    >> Share

  123. LIU J, Feng G
    A 41-year-old man with an abdominal mass and hepatomegaly.
    Gastroenterology. 2022 Aug 17. pii: S0016-5085(22)00957.
    >> Share

  124. D'ALESSIO A, Pinato DJ
    Dissecting the tumour microenvironment to predict immunotherapy response in hepatocellular cancer.
    Gastroenterology. 2022 Aug 11. pii: S0016-5085(22)00950.
    >> Share

  125. DEBOSCH B
    Targeting de novo lipogenesis by different approaches shows promise in non-alcoholic steatohepatitis.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00915.
    >> Share

  126. CLIFFORD C, Ryan R, Houlihan D
    An interesting case of hepatomegaly.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00945.
    >> Share

  127. LO GH
    The beauty and sorrow of using PPI in patients with cirrhosis.
    Gastroenterology. 2022 Aug 3. pii: S0016-5085(22)00892.
    >> Share

  128. MULLISH BH
    Further Insights Into the Impact of Bariatric Surgery on the Progression of Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2022;163:528-529.
    >> Share

  129. LE COSQUER G, Brunac AC, Peron JM
    An Unusual Case of Budd-Chiari Syndrome: Diagnosis and Treatment.
    Gastroenterology. 2022;163:e4-e5.
    >> Share

    July 2022
  130. BENHAMMOU JN, Rich NE, Cholankeril G, Zhang P, et al
    DETECT: Development of Technologies for Early HCC Detection.
    Gastroenterology. 2022;163:21-27.
    >> Share

  131. JAN J, Osho A, Murphy CC, Mazure CM, et al
    Gender, Age, Racial and Ethnic Disparities in Clinical Trial Enrollment for Primary Liver Cancer.
    Gastroenterology. 2022;163:14-20.
    >> Share

  132. TERRAULT NA, Williamson C
    Pregnancy-Associated Liver Diseases.
    Gastroenterology. 2022;163:97-117.
    >> Share

  133. KARACHALIOU GS, Shi C, Abdelmalek MF
    Liver Mass: Thinking Out of the Box.
    Gastroenterology. 2022;163:e10-e12.
    >> Share

    June 2022
  134. KIM NJ, Vutien P, Berry K, Ioannou GN, et al
    Hepatocellular carcinoma risk declines but remains high enough for screening in the first 7 years after HCV cure with DAAs in patients with cirrhosis or high FIB-4.
    Gastroenterology. 2022 Jun 28. pii: S0016-5085(22)00681.
    >> Share

  135. BLAIR AB, Wang J, Davelaar J, Baker A, et al
    Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-PD-1 therapy.
    Gastroenterology. 2022 Jun 16. pii: S0016-5085(22)00645.
    >> Share

  136. YING X, Rosenblatt R, Fortune BE
    Trends in Industry Payments to Gastroenterologists and Hepatologists in the United States from 2014 to 2020.
    Gastroenterology. 2022 Jun 14. pii: S0016-5085(22)00647.
    >> Share

  137. DUURSMA SS, Verkade HJ, Bodewes FAJA
    Cirrhosis and portal hypertension in compound heterozygous people with CF harboring one F508del CFTR gene mutation.
    Gastroenterology. 2022 Jun 10. pii: S0016-5085(22)00624.
    >> Share

  138. BAUER KC, Littlejohn PT, Ayala V, Creus-Cuadros A, et al
    Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective.
    Gastroenterology. 2022;162:1858-1875.
    >> Share

  139. SULLIVAN S, Jirapinyo P, Kumbhari V
    Clinical Care Pathway for the Risk Stratification and Management of Patients With Non-alcoholic Fatty Liver Disease.
    Gastroenterology. 2022;162:2131-2132.
    >> Share

    May 2022
  140. WANG J, Liu D, Chen S
    Proton Pump Inhibitors for Patients with Cirrhosis: Good Medicine or Poison?
    Gastroenterology. 2022 May 17. pii: S0016-5085(22)00514.
    >> Share

  141. NATSUI K, Maruyama M, Terai S
    Intrahepatic bile duct foreign body with cholangitis after pylorus preserving pancreatoduodenectomy: Is it a fish bone?
    Gastroenterology. 2022 May 14. pii: S0016-5085(22)00507.
    >> Share

  142. HU S, Molina L, Tao J, Liu S, et al
    NOTCH-YAP1/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma.
    Gastroenterology. 2022 May 9. pii: S0016-5085(22)00477.
    >> Share

  143. SINGH SP
    Proton pump inhibitor increasing the risk of infection and mortality in cirrhosis- need closer look!
    Gastroenterology. 2022 May 2. pii: S0016-5085(22)00458.
    >> Share

  144. DONNELLY MC, Stableforth W, Krag A, Reuben A, et al
    The Negative Bidirectional Interaction Between Climate Change and the Prevalence and Care of Liver Disease: A Joint BSG, BASL, EASL, and AASLD Commentary.
    Gastroenterology. 2022;162:1561-1567.
    >> Share

  145. GOUDSMIT BFJ, Putter H, Van Hoek B
    The Model for End-Stage Liver Disease 3.0: An Update Without Proven Accuracy.
    Gastroenterology. 2022;162:1781-1782.
    >> Share

  146. GAN W, Liao B, Li X
    A Rare Cause of Liver Fibrosis in Adulthood.
    Gastroenterology. 2022;162:e1-e3.
    >> Share

    April 2022
  147. CACCIOLA I
    Effects of PPIs in cirrhotic patients: What do we really know?
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00452.
    >> Share

  148. COPPS KD, Tao R
    A role for hepatic insulin signaling in alpha1-antitrypsin deficiency.
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00457.
    >> Share

  149. MAHMUD N, Serper M, Taddei TH, Kaplan DE, et al
    The Association between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients with Cirrhosis: A Veterans Affairs Cohort Study.
    Gastroenterology. 2022 Apr 6. pii: S0016-5085(22)00352.
    >> Share

  150. YANG Y, Ju C
    Sulfation in Acetaminophen-Induced Liver Injury: Friend or Foe?
    Gastroenterology. 2022;162:1035-1037.
    >> Share

  151. XU P, Xi Y, Wang P, Luka Z, et al
    Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute Liver Failure.
    Gastroenterology. 2022;162:1226-1241.
    >> Share

  152. QIAN T, Fujiwara N, Koneru B, Ono A, et al
    Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.
    Gastroenterology. 2022;162:1210-1225.
    >> Share

    March 2022
  153. RUDNICK DA, Huang J, Hidvegi T, Chu AS, et al
    Regulation of PGC1alpha downstream of the insulin signaling pathway plays a role in the hepatic proteotoxicity of mutant alpha1-antitrypsin deficiency variant Z.
    Gastroenterology. 2022 Mar 14. pii: S0016-5085(22)00261.
    >> Share

  154. VELENOSI TJ, Ben-Yakov G, Podszun MC, Hercun J, et al
    Postprandial plasma lipidomics reveal specific alteration of hepatic-derived diacylglycerols in non-alcoholic fatty liver disease.
    Gastroenterology. 2022 Mar 10. pii: S0016-5085(22)00235.
    >> Share

  155. ALTAYAR O, Shah R, Chang CY, Falck-Ytter Y, et al
    AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma.
    Gastroenterology. 2022;162:937-951.
    >> Share

  156. SU GL, Altayar O, O'Shea R, Shah R, et al
    AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma.
    Gastroenterology. 2022;162:920-934.
    >> Share

  157. MAYDEO A, Patil G
    How to Approach a Patient With Gastric Varices.
    Gastroenterology. 2022;162:689-695.
    >> Share

    February 2022
  158. CHENG N, Ren Y, Zhou J, Zhang Y, et al
    Deep learning-based classification of hepatocellular nodular lesions on whole-slide histopathologic images.
    Gastroenterology. 2022 Feb 21. pii: S0016-5085(22)00155.
    >> Share

  159. CARRIQUE L, Lynch J, Selzner N
    We thank Bekki et al and Bhagat et al for their comments on our article "Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse". Bekki et al pointed out a trend toward inferior graft su
    Gastroenterology. 2022 Feb 3. pii: S0016-5085(22)00103.
    >> Share

  160. STRAZZABOSCO M, Cabibbo G, Colombo M
    Adjusting BCLC staging system to the evolving landscape of Hepatocellular Carcinoma. A look to the future.
    Gastroenterology. 2022 Feb 2. pii: S0016-5085(22)00090.
    >> Share

  161. KANNEGANTI M, Singal AG
    INCIDENCE OF HEPATOCELLULAR CARCINOMA IN NONALCOHOLIC FATTY LIVER DISEASE.
    Gastroenterology. 2022 Feb 1. pii: S0016-5085(22)00092.
    >> Share

  162. LEE SK, Wong JC, Ng JJ
    An Uncommon Cause of Hematemesis in a Patient With End-stage Renal Disease.
    Gastroenterology. 2022;162:404-405.
    >> Share

  163. TAI Y, Wang Z, Wu H
    An Unusual Cause of Isolated Gastric Varices.
    Gastroenterology. 2022;162:e4-e6.
    >> Share

  164. QU C, Wang HY, Xiu DR
    A Rare Liver Tumor Nodule.
    Gastroenterology. 2022;162:e1-e3.
    >> Share

    January 2022
  165. WILLIAMS R, White PM, Balzora S
    "A T.E.A.M. Approach to Diversity, Equity and Inclusion in Gastroenterology and Hepatology".
    Gastroenterology. 2022 Jan 21. pii: S0016-5085(22)00035.
    >> Share

  166. WILSON SR, Duncan AW
    Single-Cell DNA Sequencing Reveals Chromosomal Diversity in HCC and a Novel Model of HCC Evolution.
    Gastroenterology. 2022;162:46-48.
    >> Share

    December 2021
  167. YANG AH, Gandhi S, Urrunaga NH
    Liver Tumor post Liver Transplantation for Hepatitis C Cirrhosis: An Unusual Cause.
    Gastroenterology. 2021 Dec 26. pii: S0016-5085(21)04161.
    >> Share

  168. FORNER A, Colombo M
    The maze of systemic therapy for hepatocellular carcinoma: did we find the compass?
    Gastroenterology. 2021 Dec 23. pii: S0016-5085(21)04121.
    >> Share

  169. KEFALAKES H
    DISPARITIES IN CIRRHOSIS MANAGEMENT OF BLACK PATIENTS: DO WE KNOW WHAT TO ADDRESS?
    Gastroenterology. 2021 Dec 1. pii: S0016-5085(21)03811.
    >> Share

  170. GERMAN MN, Brown R, Lucey MR
    Out With the Old, in With the New: Replacing the "6-Month Abstinence Rule" With Integrated Care for Alcohol-Associated Liver Disease.
    Gastroenterology. 2021;161:1795-1797.
    >> Share

  171. POLLO-FLORES P, Trebicka J
    Statins After Variceal Bleeding Are Beneficial, but Still an Unexplained Mystery?
    Gastroenterology. 2021;161:2067-2068.
    >> Share

  172. BARRITT AS 4TH, Moon AM
    Bariatric Surgery and Cancer Risk in Nonalcoholic Fatty Liver Disease-Effective Intervention for a Select Few.
    Gastroenterology. 2021;161:2063-2064.
    >> Share

  173. RAMAI D, Facciorusso A
    Liver Cancer Reduction After Bariatric Surgery: Time to Expand Its Indication?
    Gastroenterology. 2021;161:2063.
    >> Share

  174. KIM WR, Mannalithara A, Heimbach JK, Kamath PS, et al
    MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Gastroenterology. 2021;161:1887-1895.
    >> Share

  175. SACK JS, Patel RS, Ahmad J
    Nausea and Vomiting 8 Months After Liver Transplantation.
    Gastroenterology. 2021;161:e12-e14.
    >> Share

    November 2021
  176. LOOMBA R, Ratziu V, Harrison SA
    Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
    Gastroenterology. 2021 Nov 22. pii: S0016-5085(21)03795.
    >> Share

  177. BHAGAT N, Rathi S, Singh V
    Early Transplantation for Alcohol-Related Cirrhosis: Risks, Resources, and Relapse.
    Gastroenterology. 2021 Nov 5. pii: S0016-5085(21)03724.
    >> Share

  178. KANWAL F, Shubrook JH, Adams LA, Pfotenhauer K, et al
    Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2021;161:1657-1669.
    >> Share

  179. WANG X, Cheng Z
    Nodules on the Lower Legs With Ankle Joint Pain.
    Gastroenterology. 2021;161:1390-1392.
    >> Share

  180. VARGAS JF, Arab JP
    Pulsatile Epigastric Mass and Liver Masses in a 38-Year-Old Patient With Splenomegaly Since Childhood.
    Gastroenterology. 2021;161:e14-e16.
    >> Share

    October 2021
  181. LEE TH, Roper J, King L
    MIRROR MIRROR ON THE WALL, WHO IS THE FITTEST OF THEM ALL: A NOVEL PREDICTION MODEL FOR POSTOPERATIVE HEPATIC DECOMPENSATION IN PATIENTS WITH CIRRHOSIS.
    Gastroenterology. 2021 Oct 21. pii: S0016-5085(21)03662.
    >> Share

  182. LIU N, Chang CW, Steer CJ, Wang XW, et al
    MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication between Kupffer Cells and Tregs.
    Gastroenterology. 2021 Oct 19. pii: S0016-5085(21)03652.
    >> Share

  183. PEERY AF, Crockett SD, Murphy CC, Jensen ET, et al
    Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021.
    Gastroenterology. 2021 Oct 19. pii: S0016-5085(21)03655.
    >> Share

  184. LOUISSAINT J, Gibbs JT, Lok AS, Tapper EB, et al
    Strategies to Improve Video Visit Use in Persons With Liver Disease.
    Gastroenterology. 2021;161:1080-1084.
    >> Share

    September 2021
  185. INTAGLIATA NM, Davitkov P, Allen AM, Falck-Ytter YT, et al
    AGA Technical Review on Coagulation in Cirrhosis.
    Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03477.
    >> Share

  186. O'SHEA RS, Davitkov P, Ko CW, Rajasekhar A, et al
    AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.
    Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03382.
    >> Share

  187. DREYER SB, Upstill-Goddard R, Legrini A, Biankin AV, et al
    Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence.
    Gastroenterology. 2021 Sep 14. pii: S0016-5085(21)03522.
    >> Share

  188. BEKKI Y, Fenig Y
    Evaluation of Early Liver Transplantation for Alcohol-Related Cirrhosis.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03491.
    >> Share

  189. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide for Programs, Faculty, and Fellows.
    Gastroenterology. 2021 Sep 3. pii: S0016-5085(21)03335.
    >> Share

  190. GUO L, Yi X, Chen L, Zhang T, et al
    Single cell DNA sequencing reveals punctuated and gradual clonal evolution in hepatocellular carcinoma.
    Gastroenterology. 2021 Sep 2. pii: S0016-5085(21)03471.
    >> Share

  191. KANWAL F, Shubrook JH, Younossi Z, Natarajan Y, et al
    Preparing for the NASH Epidemic: A Call to Action.
    Gastroenterology. 2021;161:1030-1042.
    >> Share

  192. HABER PK, Puigvehi M, Castet F, Lourdusamy V, et al
    Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).
    Gastroenterology. 2021;161:879-898.
    >> Share

  193. DE BUCOURT M
    A Visual Engram Worth Remembering.
    Gastroenterology. 2021;161:809-810.
    >> Share

  194. FUCHS A, Samovski D, Smith GI, Cifarelli V, et al
    Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2021;161:968-981.
    >> Share

    August 2021
  195. BALZORA S, May FP, Ogedegbe G
    COVID-19 and Social Determinants of Health in Gastroenterology and Hepatology.
    Gastroenterology. 2021 Aug 26. pii: S0016-5085(21)03438.
    >> Share

  196. SU F
    COVID-19 and cirrhosis: a combination we must strive to prevent.
    Gastroenterology. 2021 Aug 25. pii: S0016-5085(21)03417.
    >> Share

  197. AZZIMATO V, Chen P, Barreby E, Morgantini C, et al
    Hepatic miR-144 drives fumarase activity preventing NRF2 activation during obesity.
    Gastroenterology. 2021 Aug 20. pii: S0016-5085(21)03410.
    >> Share

  198. OLYNYK JK, Ramm GA
    RISK OF LIVER CANCER IN HFE-HEMOCHROMATOSIS.
    Gastroenterology. 2021 Aug 19. pii: S0016-5085(21)03405.
    >> Share

  199. TAI CS, Ni YH, Lee PI
    An Unusual Case with a Huge Hepatic Cystic Mass.
    Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03357.
    >> Share

  200. CARRIQUE L, Quance J, Tan A, Abbey S, et al
    Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse.
    Gastroenterology. 2021 Aug 6. pii: S0016-5085(21)03342.
    >> Share

  201. GOUGH NR, Xiang X, Mishra L
    TGF-beta Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer.
    Gastroenterology. 2021;161:434-452.
    >> Share

    July 2021
  202. MEHTA N, Frenette C, Tabrizian P, Hoteit M, et al
    Down-staging Outcomes for Hepatocellular Carcinoma: Results from the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
    Gastroenterology. 2021 Jul 28. pii: S0016-5085(21)03284.
    >> Share

  203. LOOMBA R, Mohseni R, Lucas KJ, Gutierrez JA, et al
    TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled Ph2a trial.
    Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03276.
    >> Share

  204. GE J, Pletcher MJ, Lai JC
    Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study.
    Gastroenterology. 2021 Jul 17. pii: S0016-5085(21)03244.
    >> Share

  205. YE P, Miao H, Chen Y
    An unusual case of symptomatic portal hypertension.
    Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03253.
    >> Share

  206. MAAN R, Darwish Murad S, van der Meer AJ
    Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;161:371-372.
    >> Share

  207. LI L, Liu C, Qi X
    Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;161:370-371.
    >> Share

  208. PARIKH ND, Chung GS, Mellinger J, Blanchette JG, et al
    Alcohol Policies and Alcohol-related Liver Disease Mortality.
    Gastroenterology. 2021;161:350-352.
    >> Share

  209. RUSTGI VK, Li Y, Gupta K, Minacapelli CD, et al
    Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity.
    Gastroenterology. 2021;161:171-184.
    >> Share

  210. SURAPANENI PK, Mills K, Renelus BD
    A Rare Complication of Sickle Cell Anemia.
    Gastroenterology. 2021;161:45-46.
    >> Share

    June 2021
  211. CHIANG HC, Chien SC, Lin YJ
    Pleural effusion with gastric ulcer.
    Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03176.
    >> Share

  212. TSOI AH, Garg M, Tsoi EH
    Peptic ulcer disease: an unusual presentation of a common problem.
    Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03174.
    >> Share

  213. VALENTI L, Mondelli M, Colombo M
    Liver field during immunotherapy of hepatocellular carcinoma: some like it hot.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03165.
    >> Share

  214. LI H, Liu H
    Recurrent Epistaxis and Diffuse Hepatic and Splenic Vascular Malformations.
    Gastroenterology. 2021 Jun 8. pii: S0016-5085(21)03091.
    >> Share

  215. MEDICI V
    Expanding the Diagnostic Toolkit of Wilson Disease with ATP7B Peptides.
    Gastroenterology. 2021;160:2249-2251.
    >> Share

  216. SU P, Hong J, Li T
    An Uncommon Lesion of the Liver.
    Gastroenterology. 2021;160:2258-2260.
    >> Share

  217. COLLINS CJ, Yi F, Dayuha R, Duong P, et al
    Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease.
    Gastroenterology. 2021;160:2367-2382.
    >> Share

    May 2021
  218. EDWARDS LA, Goldenberg SD, Shawcross DL
    Meeting the challenge of antimicrobial resistance in cirrhosis: the invisible threat that lies within.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03065.
    >> Share

  219. GARCIA-TSAO G, Abraldes JG
    Non-selective beta-blockers in compensated cirrhosis: Preventing variceal hemorrhage or preventing decompensation?
    Gastroenterology. 2021 May 11. pii: S0016-5085(21)02972.
    >> Share

  220. PERRY IE, Azam MU, Yap JE
    Carcinoma Camouflage.
    Gastroenterology. 2021;160:1940-1942.
    >> Share

  221. SHEN C, Zong Z, Xu N
    "Malignant" Liver Cysts Cause Liver Failure and Recurrence.
    Gastroenterology. 2021;160:e7-e9.
    >> Share

  222. NAYAK LJ, Sondhi AR, Westerhoff M
    History!
    Gastroenterology. 2021;160:e5-e6.
    >> Share

  223. HA NB, Wang CW, El-Nachef N
    An Unusual Mechanical Cause of Upper Gastrointestinal Hemorrhage.
    Gastroenterology. 2021;160:e1-e4.
    >> Share

    April 2021
  224. PACK M
    Model Organisms Help Define the ABCs of Neonatal Cholestasis.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00636.
    >> Share

  225. SHAMSADDINI A, Gillevet PM, Acharya C, Fagan A, et al
    Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients with Cirrhosis.
    Gastroenterology. 2021 Apr 12. pii: S0016-5085(21)00634.
    >> Share

  226. SHEEHAN JL, Brandler J, Rice MD
    A Case of Recurrent Hepatic Abscesses.
    Gastroenterology. 2021 Apr 8. pii: S0016-5085(21)00627.
    >> Share

  227. PONZIANI FR, Nesci A, Del Zompo F, Santopaolo F, et al
    Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection.
    Gastroenterology. 2021;160:1891-1893.
    >> Share

  228. KHAN MU, Mushtaq K, Alkaabi SR
    Acute-on-Chronic Liver Failure: Possibly the Main Culprit of Increased Mortality in COVID-19 Patients with Liver Disease.
    Gastroenterology. 2021;160:1894-1895.
    >> Share

  229. VERMA N, Duseja A, Singh V
    Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease.
    Gastroenterology. 2021;160:1893-1894.
    >> Share

  230. LUUKKONEN PK, Salomaa V, Aberg F
    The Pi *MZ Allele in Alpha-1 Antitrypsin Increases Liver-Related Outcomes in a Population-Based Study.
    Gastroenterology. 2021;160:1874-1875.
    >> Share

  231. JAMIALAHMADI O, Mancina RM, Ciociola E, Tavaglione F, et al
    Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
    Gastroenterology. 2021;160:1634-1646.
    >> Share

    March 2021
  232. ASSELTA R, Paraboschi EM, Gerussi A, Cordell HJ, et al
    X chromosome contribution to the genetic architecture of primary biliary cholangitis.
    Gastroenterology. 2021 Mar 3. pii: S0016-5085(21)00466.
    >> Share

  233. CASADEI-GARDINI A, Cascinu S, Colombo M
    Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?
    Gastroenterology. 2021;160:1423-1424.
    >> Share

  234. GOLDBERG D, Ross-Driscoll K, Lynch R
    County Differences in Liver Mortality in the United States: Impact of Sociodemographics, Disease Risk Factors, and Access to Care.
    Gastroenterology. 2021;160:1140-1150.
    >> Share

  235. KOBAYASHI H, Gieniec KA, Wright JA, Wang T, et al
    The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
    Gastroenterology. 2021;160:1224-1239.
    >> Share

  236. PRZYBYSZEWSKI EM, Deshpande V, Uchida AM
    An Unsuspected Cause of Rectal Bleeding.
    Gastroenterology. 2021;160:e1-e2.
    >> Share

    February 2021
  237. YOUNOSSI ZM, Corey KE, Lim JK
    AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2021;160:912-918.
    >> Share

  238. SHINOZAWA T, Kimura M, Cai Y, Saiki N, et al
    High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.
    Gastroenterology. 2021;160:831-846.
    >> Share

  239. NASSANI N, Melitas C, Villa E
    An Unusual Cause of Watery Diarrhea.
    Gastroenterology. 2021;160:671-674.
    >> Share

    January 2021
  240. BHAT S, Farraye FA, Hayney MS, Caldera F, et al
    How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease.
    Gastroenterology. 2021 Jan 15. pii: S0016-5085(21)00093.
    >> Share

  241. ACHARYA C, Bajaj JS
    Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.
    Gastroenterology. 2021;160:556-572.
    >> Share

  242. NICOARA-FARCAU O, Han G, Rudler M, Angrisani D, et al
    Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;160:193-205.
    >> Share

    December 2020
  243. VAN DIJK M, Weehuizen TAF, Lowenberg M
    A rare cause of acute abdominal pain after endoscopic retrograde cholangiopancreaticography.
    Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35559.
    >> Share

  244. ARVIND A, Osganian SA, Sjoquist JA, Corey KE, et al
    Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis.
    Gastroenterology. 2020;159:2232-2234.
    >> Share

    November 2020
  245. NOUREDDIN M, Jones C, Alkhouri N, Gomez EV, et al
    Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis.
    Gastroenterology. 2020;159:1985-1987.
    >> Share

  246. XANTHAKOS SA, Lavine JE, Yates KP, Schwimmer JB, et al
    Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
    Gastroenterology. 2020;159:1731-1751.
    >> Share

  247. LANG S, Demir M, Martin A, Jiang L, et al
    Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2020;159:1839-1852.
    >> Share

    October 2020
  248. VERBOVEN E, Moya IM, Sansores-Garcia L, Xie J, et al
    Regeneration Defects in Yap and Taz Mutant Mouse Livers are Caused by Bile Duct Disruption and Cholestasis.
    Gastroenterology. 2020 Oct 27. pii: S0016-5085(20)35324.
    >> Share

  249. DOUGAN M, Wang Y, Rubio-Tapia A, Lim JK, et al
    AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor (ICI) Colitis and Hepatitis: Expert Review.
    Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35282.
    >> Share

  250. ASEEM SO, Jalan-Sakrikar N, Chi C, Navarro-Corcuera A, et al
    Epigenomic Evaluation of Cholangiocyte TGFbeta Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
    Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35245.
    >> Share

  251. DE VRIES E, Bolier R, Goet J, Pares A, et al
    Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double blind, randomized, placebo-controlled trial.
    Gastroenterology. 2020 Oct 5. pii: S0016-5085(20)35226.
    >> Share

  252. ROMEO S
    MARC1 and HNRNPUL1: Two Novel Players in Alcohol-related Liver Disease.
    Gastroenterology. 2020;159:1231-1232.
    >> Share

  253. RAMLI MNB, Lim YS, Koe CT, Demircioglu D, et al
    Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease.
    Gastroenterology. 2020;159:1471-1486.
    >> Share

    September 2020
  254. VILAR-GOMEZ E, Sookoian S, Pirola CJ, Liang T, et al
    ADH1B *2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
    Gastroenterology. 2020;159:929-943.
    >> Share

  255. CHAI C, Cox B, Yaish D, Gross D, et al
    Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Gastroenterology. 2020;159:999-1014.
    >> Share

  256. WANG Y, Pan Y, Zhou Z
    An Unusual Cause of Fever in a Man With a Liver Mass.
    Gastroenterology. 2020;159:842-844.
    >> Share

    August 2020
  257. JANSSON-KNODELL CL, Walker MJ, Fischer M
    Pancytopenia in a Young Male Patient with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Aug 7. pii: S0016-5085(20)35027.
    >> Share

  258. NABI O, Lacombe K, Boursier J, Mathurin P, et al
    Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.
    Gastroenterology. 2020;159:791-793.
    >> Share

  259. SCHNEIDER CV, Hamesch K, Gross A, Mandorfer M, et al
    Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi *Z Variant of AAT (Pi *MZ vs Pi *ZZ genotype) and Noncarriers.
    Gastroenterology. 2020;159:534-548.
    >> Share

  260. GUPTA V, Gupta I, Park J, Bram Y, et al
    Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.
    Gastroenterology. 2020;159:624-638.
    >> Share

  261. NAUDIN CR, Maner-Smith K, Owens JA, Wynn GM, et al
    Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.
    Gastroenterology. 2020;159:639-651.
    >> Share

    June 2020
  262. RUETHER DF, Menz A, Manthey CF
    A Dishevelled Man with Inflammatory Bowel Disease and Signs of Infection.
    Gastroenterology. 2020 Jun 5. pii: S0016-5085(20)34749.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016